Duke University Medical Center, Morris Cancer Clinic

Durham, North Carolina 27710

0 studies enrolling now · 2 studies all time

What they study most

KRAS p.G12C Mutant Advanced Solid Tumors, Non-small Cell Lung Cancer

Studies at this site

• A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment — Stopped early
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed